Fatal subcutaneous panniculitis-like T-cell lymphoma γ/δ subtype (cutaneous γ/δ T-cell lymphoma)

Report of a case and review of the literature

Grace F. Kao, Brooke Resh, Christine McMahon, Ivana Gojo, Chen Chih Sun, Daniel Phillips, Xianfeng Frank Zhao

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Subcutaneous panniculitis-like T-cell lymphoma (SPTCL) is a distinct type of peripheral T-cell lymphoma, which has gained recognition over the past decade. The disease presents complex clinical, pathologic, and immunohistochemical features, which warrant awareness by dermatologists, dermatopathologists, hematopathologists, hematologists, oncologists, and internists. SPTCL was initially included as a provisional entity in the Revised European-American Lymphoma classification, followed by the European Organization for Research and Treatment of Cancer classification as a primary cutaneous lymphoma, and subsequently as a distinct entity by the World Health Organization classification. It is known that patients diagnosed with SPTCL usually respond poorly to therapy, and the tumor progresses aggressively. Data from recent studies in a series of cases of SPTCL by the European Organization for Research and Treatment of Cancer Cutaneous Lymphoma Group have further identified SPTCL as a heterogeneous disease entity, which comprises an α/β subtype (SPTCL-AB) and a γ/δ subtype (SPTCL-GD). The latter has recently been included in the entity of "cutaneous γ/δ T-cell lymphoma" by the World Health Organization, Pathology and Genetics of Skin Tumours. The clinical, histologic, and immunophenotypic data, treatment, and prognosis, appear different in the 2 subtypes of SPTCL. We report a case of fatal SPTCL-GD (cutaneous γ/δ T-cell lymphoma), with detailed clinicopathologic features, immunohistochemical studies, treatment, and clinical course. In view of its aggressive behavior, identification of this disease is critical for proper management and treatment.

Original languageEnglish (US)
Pages (from-to)593-599
Number of pages7
JournalAmerican Journal of Dermatopathology
Volume30
Issue number6
DOIs
StatePublished - Dec 2008
Externally publishedYes

Fingerprint

Cutaneous T-Cell Lymphoma
Lymphoma
Therapeutics
Organizations
Peripheral T-Cell Lymphoma
Subcutaneous panniculitis-like T-cell lymphoma
Neoplasms
Skin
Skin Neoplasms
Research
Pathology

Keywords

  • Cutaneous T-cell lymphoma
  • Panniculitis

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Dermatology
  • Medicine(all)

Cite this

Fatal subcutaneous panniculitis-like T-cell lymphoma γ/δ subtype (cutaneous γ/δ T-cell lymphoma) : Report of a case and review of the literature. / Kao, Grace F.; Resh, Brooke; McMahon, Christine; Gojo, Ivana; Sun, Chen Chih; Phillips, Daniel; Zhao, Xianfeng Frank.

In: American Journal of Dermatopathology, Vol. 30, No. 6, 12.2008, p. 593-599.

Research output: Contribution to journalArticle

Kao, Grace F. ; Resh, Brooke ; McMahon, Christine ; Gojo, Ivana ; Sun, Chen Chih ; Phillips, Daniel ; Zhao, Xianfeng Frank. / Fatal subcutaneous panniculitis-like T-cell lymphoma γ/δ subtype (cutaneous γ/δ T-cell lymphoma) : Report of a case and review of the literature. In: American Journal of Dermatopathology. 2008 ; Vol. 30, No. 6. pp. 593-599.
@article{5e1031cf9ff7485e8aab4ba06968eb66,
title = "Fatal subcutaneous panniculitis-like T-cell lymphoma γ/δ subtype (cutaneous γ/δ T-cell lymphoma): Report of a case and review of the literature",
abstract = "Subcutaneous panniculitis-like T-cell lymphoma (SPTCL) is a distinct type of peripheral T-cell lymphoma, which has gained recognition over the past decade. The disease presents complex clinical, pathologic, and immunohistochemical features, which warrant awareness by dermatologists, dermatopathologists, hematopathologists, hematologists, oncologists, and internists. SPTCL was initially included as a provisional entity in the Revised European-American Lymphoma classification, followed by the European Organization for Research and Treatment of Cancer classification as a primary cutaneous lymphoma, and subsequently as a distinct entity by the World Health Organization classification. It is known that patients diagnosed with SPTCL usually respond poorly to therapy, and the tumor progresses aggressively. Data from recent studies in a series of cases of SPTCL by the European Organization for Research and Treatment of Cancer Cutaneous Lymphoma Group have further identified SPTCL as a heterogeneous disease entity, which comprises an α/β subtype (SPTCL-AB) and a γ/δ subtype (SPTCL-GD). The latter has recently been included in the entity of {"}cutaneous γ/δ T-cell lymphoma{"} by the World Health Organization, Pathology and Genetics of Skin Tumours. The clinical, histologic, and immunophenotypic data, treatment, and prognosis, appear different in the 2 subtypes of SPTCL. We report a case of fatal SPTCL-GD (cutaneous γ/δ T-cell lymphoma), with detailed clinicopathologic features, immunohistochemical studies, treatment, and clinical course. In view of its aggressive behavior, identification of this disease is critical for proper management and treatment.",
keywords = "Cutaneous T-cell lymphoma, Panniculitis",
author = "Kao, {Grace F.} and Brooke Resh and Christine McMahon and Ivana Gojo and Sun, {Chen Chih} and Daniel Phillips and Zhao, {Xianfeng Frank}",
year = "2008",
month = "12",
doi = "10.1097/DAD.0b013e318182c7bf",
language = "English (US)",
volume = "30",
pages = "593--599",
journal = "American Journal of Dermatopathology",
issn = "0193-1091",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - Fatal subcutaneous panniculitis-like T-cell lymphoma γ/δ subtype (cutaneous γ/δ T-cell lymphoma)

T2 - Report of a case and review of the literature

AU - Kao, Grace F.

AU - Resh, Brooke

AU - McMahon, Christine

AU - Gojo, Ivana

AU - Sun, Chen Chih

AU - Phillips, Daniel

AU - Zhao, Xianfeng Frank

PY - 2008/12

Y1 - 2008/12

N2 - Subcutaneous panniculitis-like T-cell lymphoma (SPTCL) is a distinct type of peripheral T-cell lymphoma, which has gained recognition over the past decade. The disease presents complex clinical, pathologic, and immunohistochemical features, which warrant awareness by dermatologists, dermatopathologists, hematopathologists, hematologists, oncologists, and internists. SPTCL was initially included as a provisional entity in the Revised European-American Lymphoma classification, followed by the European Organization for Research and Treatment of Cancer classification as a primary cutaneous lymphoma, and subsequently as a distinct entity by the World Health Organization classification. It is known that patients diagnosed with SPTCL usually respond poorly to therapy, and the tumor progresses aggressively. Data from recent studies in a series of cases of SPTCL by the European Organization for Research and Treatment of Cancer Cutaneous Lymphoma Group have further identified SPTCL as a heterogeneous disease entity, which comprises an α/β subtype (SPTCL-AB) and a γ/δ subtype (SPTCL-GD). The latter has recently been included in the entity of "cutaneous γ/δ T-cell lymphoma" by the World Health Organization, Pathology and Genetics of Skin Tumours. The clinical, histologic, and immunophenotypic data, treatment, and prognosis, appear different in the 2 subtypes of SPTCL. We report a case of fatal SPTCL-GD (cutaneous γ/δ T-cell lymphoma), with detailed clinicopathologic features, immunohistochemical studies, treatment, and clinical course. In view of its aggressive behavior, identification of this disease is critical for proper management and treatment.

AB - Subcutaneous panniculitis-like T-cell lymphoma (SPTCL) is a distinct type of peripheral T-cell lymphoma, which has gained recognition over the past decade. The disease presents complex clinical, pathologic, and immunohistochemical features, which warrant awareness by dermatologists, dermatopathologists, hematopathologists, hematologists, oncologists, and internists. SPTCL was initially included as a provisional entity in the Revised European-American Lymphoma classification, followed by the European Organization for Research and Treatment of Cancer classification as a primary cutaneous lymphoma, and subsequently as a distinct entity by the World Health Organization classification. It is known that patients diagnosed with SPTCL usually respond poorly to therapy, and the tumor progresses aggressively. Data from recent studies in a series of cases of SPTCL by the European Organization for Research and Treatment of Cancer Cutaneous Lymphoma Group have further identified SPTCL as a heterogeneous disease entity, which comprises an α/β subtype (SPTCL-AB) and a γ/δ subtype (SPTCL-GD). The latter has recently been included in the entity of "cutaneous γ/δ T-cell lymphoma" by the World Health Organization, Pathology and Genetics of Skin Tumours. The clinical, histologic, and immunophenotypic data, treatment, and prognosis, appear different in the 2 subtypes of SPTCL. We report a case of fatal SPTCL-GD (cutaneous γ/δ T-cell lymphoma), with detailed clinicopathologic features, immunohistochemical studies, treatment, and clinical course. In view of its aggressive behavior, identification of this disease is critical for proper management and treatment.

KW - Cutaneous T-cell lymphoma

KW - Panniculitis

UR - http://www.scopus.com/inward/record.url?scp=59849113227&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=59849113227&partnerID=8YFLogxK

U2 - 10.1097/DAD.0b013e318182c7bf

DO - 10.1097/DAD.0b013e318182c7bf

M3 - Article

VL - 30

SP - 593

EP - 599

JO - American Journal of Dermatopathology

JF - American Journal of Dermatopathology

SN - 0193-1091

IS - 6

ER -